Note 9 - Major Clients	12 Months Ended
Jan. 31, 2025
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	NOTE 9 — MAJOR CLIENTS During fiscal 2024, the Company did not have any one individual client account for 10% or more of our revenue. In the third quarter of fiscal 2023, the Company received notice from a client of its intent not to renew its contract for the Company’s SaaS solutions following the expiration of the contract’s term on December 31, 2023. Revenue recognized related to that client’s SaaS contract represented approximately 19% of total revenue for fiscal 2023, and the Company recognized no SaaS revenue from that client in fiscal 2024. Three clients represented 20%, 20%, and 14%, respectively, of accounts receivable as of January 31, 2025, and four clients represented 14%, 12%, 12% and 11%, respectively, of accounts receivable as of January 31, 2024. Many of our clients are invoiced on an annual basis.

Note 9 - Major Clients

12 Months Ended

Jan. 31, 2025

Concentration Risk Disclosure [Text Block]

NOTE 9 — MAJOR CLIENTS

During fiscal 2024, the Company did not have any one individual client account for 10% or more of our revenue. In the third quarter of fiscal 2023, the Company received notice from a client of its intent not to renew its contract for the Company’s SaaS solutions following the expiration of the contract’s term on December 31, 2023. Revenue recognized related to that client’s SaaS contract represented approximately 19% of total revenue for fiscal 2023, and the Company recognized no SaaS revenue from that client in fiscal 2024. Three clients represented 20%, 20%, and 14%, respectively, of accounts receivable as of January 31, 2025, and four clients represented 14%, 12%, 12% and 11%, respectively, of accounts receivable as of January 31, 2024. Many of our clients are invoiced on an annual basis.

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (d)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/275/tableOfContent

+ Details

STREAMLINE HEALTH SOLUTIONS INC. 10-K